Greykasell Wealth Strategies’s Chemours CC Stock Holding History

Greykasell Wealth Strategies’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-61	Closed	-$823	–	316
2025 Q1	$823	Buy	+61	New	+$1.01K	﹤0.01%	336

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Greykasell Wealth Strategies's CC Position: Q2 2025 in Review

Greykasell Wealth Strategies sold out of Chemours (CC) in Q2 2025, closing a stake of 61 shares — an estimated $823 sold.

Greykasell Wealth Strategies first reported a position in CC in Q1 2025 and held it in 1 quarter. The position peaked at $823 in Q1 2025. 434 funds tracked by Wall St. Rank hold CC as of Q2 2025.

Greykasell Wealth Strategies reported no remaining Chemours position as of Q2 2025 after selling out during the quarter.
Greykasell Wealth Strategies sold 61 Chemours shares in Q2 2025, an estimated $823.
Greykasell Wealth Strategies first reported a position in Chemours in Q1 2025 and held it in 1 quarter.
Greykasell Wealth Strategies's Chemours position peaked at $823 in Q1 2025.
434 funds tracked by Wall St. Rank held Chemours as of Q2 2025.

Based on Greykasell Wealth Strategies's 13F filing for Q2 2025, filed 11 Aug 2025.